Axis Biotec Brasil is a holding company that sponsors and manages research, development and innovative business in the health and life sectors. With strong expertise in R&D, and also in sales and marketing, over the last 30 years, the companies of the group have been successful in translating research into innovative products and services in the health sector. Today, Axis Biotec is the major shareholder in four companies in Brazil: Silvestre Labs (pharmaceutical company), Cryopraxis (long-term biological material cryogenic bank), CellPraxis (bioengineering company focused in regenerative medicine and cell therapy) and PharmaPraxis (biopharmaceutical corporation). These companies, located in Rio de Janeiro’s Biotech Development Park, directly employ over 200 professionals and involve another 500 in various projects.
If you are interested in finding out more about Axis Biotec’s projects, contact us: www.axisbiotec.com
Company Details
- Employees
- 8
- Founded
- -
- Address
- Av. Carlos Chagas Filho, 791 - Cidade Universitária Ilha Do Fundão, Rio De Janeiro,rj 21.941-904,brazil
- Industry
- Biotechnology
- Website
- http://axisbiotec.com.br/
- Keywords
- in the health sector. Today.
- HQ
- Rio de Janeiro, RJ
Axis Biotec Brasil Questions
Axis Biotec Brasil's website is http://axisbiotec.com.br/
Axis Biotec Brasil's LinkedIn profile is https://br.linkedin.com/company/axis-biotec-brasil
Axis Biotec Brasil has
8 employees.
View email and phone details for 8
employees at Axis Biotec Brasil.
Axis Biotec Brasil's industry is
Biotechnology
Axis Biotec Brasil's top competitors are
Silvestre Labs Quimica E Farmaceutica Ltda,
R-Crio | Stem Cells,
Bionovis,
Cellpreserve - Centro De Biotecnologia,
Stemcorp,
Cordvida,
Hemocord Biotecnologia,
Cryopraxis®,
Silvestre Labs,
Cellpraxis®.
Axis Biotec Brasil's categories are Biotechnology
Axis Biotec Brasil's founding year is 1984
